Ionizing radiations induce shared epigenomic signatures unraveling adaptive mechanisms of cancerous cell lines with or without methionine dependency.

Aberrant methylation Epigenome alterations Epigenome-wide association study Glioblastoma Hepatocellular carcinoma Ionizing radiation Melanoma Metabolic adaptation in cancer Methionine dependency Radiation therapy Radioresistance

Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 16 07 2021
accepted: 12 11 2021
entrez: 2 12 2021
pubmed: 3 12 2021
medline: 1 2 2022
Statut: epublish

Résumé

Although radiation therapy represents a core cancer treatment modality, its efficacy is hampered by radioresistance. The effect of ionizing radiations (IRs) is well known regarding their ability to induce genetic alterations; however, their impact on the epigenome landscape in cancer, notably at the CpG dinucleotide resolution, remains to be further deciphered. In addition, no evidence is available regarding the effect of IRs on the DNA methylome profile according to the methionine dependency phenotype, which represents a hallmark of metabolic adaptation in cancer. We used a case-control study design with a fractionated irradiation regimen on four cancerous cell lines representative of HCC (HepG2), melanoma (MeWo and MeWo-LC1, which exhibit opposed methionine dependency phenotypes), and glioblastoma (U251). We performed high-resolution genome-wide DNA methylome profiling using the MethylationEPIC BeadChip on baseline conditions, irradiated cell lines (cumulative dose of 10 Gy), and non-irradiated counterparts. We performed epigenome-wide association studies to assess the effect of IRs and methionine-dependency-oriented analysis by carrying out epigenome-wide conditional logistic regression. We looked for epigenome signatures at the locus and single-probe (CpG dinucleotide) levels and through enrichment analyses of gene ontologies (GO). The EpiMet project was registered under the ID#AAP-BMS_003_211. EWASs revealed shared GO annotation pathways associated with increased methylation signatures for several biological processes in response to IRs, including blood circulation, plasma membrane-bounded cell projection organization, cell projection organization, multicellular organismal process, developmental process, and animal organ morphogenesis. Epigenome-wide conditional logistic regression analysis on the methionine dependency phenotype highlighted several epigenome signatures related to cell cycle and division and responses to IR and ultraviolet light. IRs generated a variation in the methylation level of a high number of CpG probes with shared biological pathways, including those associated with cell cycle and division, responses to IRs, sustained angiogenesis, tissue invasion, and metastasis. These results provide insight on shared adaptive mechanisms of the epigenome in cancerous cell lines in response to IR. Future experiments should focus on the tryptic association between IRs, the initiation of a radioresistance phenotype, and their interaction with methionine dependency as a hallmark of metabolic adaptation in cancer.

Sections du résumé

BACKGROUND
Although radiation therapy represents a core cancer treatment modality, its efficacy is hampered by radioresistance. The effect of ionizing radiations (IRs) is well known regarding their ability to induce genetic alterations; however, their impact on the epigenome landscape in cancer, notably at the CpG dinucleotide resolution, remains to be further deciphered. In addition, no evidence is available regarding the effect of IRs on the DNA methylome profile according to the methionine dependency phenotype, which represents a hallmark of metabolic adaptation in cancer.
METHODS
We used a case-control study design with a fractionated irradiation regimen on four cancerous cell lines representative of HCC (HepG2), melanoma (MeWo and MeWo-LC1, which exhibit opposed methionine dependency phenotypes), and glioblastoma (U251). We performed high-resolution genome-wide DNA methylome profiling using the MethylationEPIC BeadChip on baseline conditions, irradiated cell lines (cumulative dose of 10 Gy), and non-irradiated counterparts. We performed epigenome-wide association studies to assess the effect of IRs and methionine-dependency-oriented analysis by carrying out epigenome-wide conditional logistic regression. We looked for epigenome signatures at the locus and single-probe (CpG dinucleotide) levels and through enrichment analyses of gene ontologies (GO). The EpiMet project was registered under the ID#AAP-BMS_003_211.
RESULTS
EWASs revealed shared GO annotation pathways associated with increased methylation signatures for several biological processes in response to IRs, including blood circulation, plasma membrane-bounded cell projection organization, cell projection organization, multicellular organismal process, developmental process, and animal organ morphogenesis. Epigenome-wide conditional logistic regression analysis on the methionine dependency phenotype highlighted several epigenome signatures related to cell cycle and division and responses to IR and ultraviolet light.
CONCLUSIONS
IRs generated a variation in the methylation level of a high number of CpG probes with shared biological pathways, including those associated with cell cycle and division, responses to IRs, sustained angiogenesis, tissue invasion, and metastasis. These results provide insight on shared adaptive mechanisms of the epigenome in cancerous cell lines in response to IR. Future experiments should focus on the tryptic association between IRs, the initiation of a radioresistance phenotype, and their interaction with methionine dependency as a hallmark of metabolic adaptation in cancer.

Identifiants

pubmed: 34852845
doi: 10.1186/s13148-021-01199-y
pii: 10.1186/s13148-021-01199-y
pmc: PMC8638416
doi:

Substances chimiques

Methionine AE28F7PNPL

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

212

Subventions

Organisme : la ligue contre le cancer (grand est/bourgogne franche comté, france)
ID : 3FI14040UHSK
Organisme : university of lorraine (pôle biologie médecine santé)
ID : AAP-BMS_003_211

Informations de copyright

© 2021. The Author(s).

Références

Int J Radiat Biol. 2017 May;93(5):457-469
pubmed: 28134023
PLoS One. 2012;7(10):e45394
pubmed: 23077491
Nat Protoc. 2013 Aug;8(8):1551-66
pubmed: 23868073
Nat Commun. 2018 May 16;9(1):1955
pubmed: 29769529
Epigenetics. 2018;13(12):1141-1153
pubmed: 30458693
PLoS One. 2011;6(7):e21800
pubmed: 21789182
PLoS One. 2009 Jul 27;4(7):e6377
pubmed: 19633716
J Neurooncol. 2020 Nov;150(2):269-359
pubmed: 33215345
Radiat Oncol. 2021 Feb 18;16(1):36
pubmed: 33602305
Oncology (Williston Park). 2004 Jan;18(1):99-107; discussion 107-10, 113-4
pubmed: 14768409
Epigenetics. 2013 Aug;8(8):839-48
pubmed: 23880508
Lancet Neurol. 2019 Apr;18(4):376-393
pubmed: 30797715
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Science. 1999 Oct 15;286(5439):481-6
pubmed: 10521337
Gastroenterology. 2016 Apr;150(4):835-53
pubmed: 26795574
PLoS One. 2012;7(2):e31028
pubmed: 22347422
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1265-1275
pubmed: 32712256
Mol Genet Metab. 2009 Apr;96(4):261-7
pubmed: 19200761
Oncotarget. 2016 Aug 17;8(38):62842-62857
pubmed: 28968953
Sci Signal. 2014 May 13;7(325):rs3
pubmed: 24825921
Radiother Oncol. 2014 May;111(2):168-77
pubmed: 24861629
Clin Epigenetics. 2020 Feb 11;12(1):26
pubmed: 32046773
Anticancer Res. 2019 Sep;39(9):4667-4671
pubmed: 31519565
Cell Mol Life Sci. 2019 Apr;76(7):1397-1417
pubmed: 30673822
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
N Engl J Med. 2018 Apr 05;378(14):1323-1334
pubmed: 29617578
Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):968-976
pubmed: 31536781
J Cell Biochem. 2015 Feb;116(2):212-7
pubmed: 25186310
Int J Radiat Oncol Biol Phys. 2020 May 1;107(1):116-125
pubmed: 32001057
Nat Commun. 2018 Jan 4;9(1):67
pubmed: 29302025
PLoS Genet. 2018 Jun 7;14(6):e1007362
pubmed: 29879107
Annu Rev Cancer Biol. 2021 Mar;5(1):235-257
pubmed: 34109280
Lancet. 2018 Sep 1;392(10149):777-786
pubmed: 30100054
Epigenetics. 2015;10(6):545-61
pubmed: 25961636
Nat Rev Genet. 2016 Sep 15;17(10):630-41
pubmed: 27629931
Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):464-473
pubmed: 33229165
Biomol Concepts. 2017 May 24;8(2):83-92
pubmed: 28574375
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):767-778
pubmed: 29976487
Mutat Res. 2012 Oct-Dec;751(2):258-286
pubmed: 22677531
Acta Biochim Biophys Sin (Shanghai). 2018 Aug 1;50(8):733-739
pubmed: 29889218
Pract Radiat Oncol. 2016 Jul-Aug;6(4):217-225
pubmed: 27211230
Cancer Treat Rev. 2012 Oct;38(6):726-36
pubmed: 22342103
Annu Rev Biomed Eng. 2017 Jun 21;19:195-219
pubmed: 28301736
N Engl J Med. 2011 Sep 22;365(12):1118-27
pubmed: 21992124
Radiother Oncol. 2001 May;59(2):203-12
pubmed: 11325450
Nat Med. 2019 May;25(5):825-837
pubmed: 31061538
Arch Gynecol Obstet. 2014 Jun;289(6):1315-23
pubmed: 24385285
Nat Rev Cancer. 2016 Nov;16(11):694-707
pubmed: 27634449
Expert Opin Biol Ther. 2015 Jan;15(1):21-31
pubmed: 25439528
Clin Epigenetics. 2021 May 29;13(1):120
pubmed: 34051847
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):13000-13011
pubmed: 32434918

Auteurs

Youssef Siblini (Y)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.

Céline Chéry (C)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.
Department of Molecular Medicine and Personalized Therapeutics, Department of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France.
Reference Center for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France.

Pierre Rouyer (P)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.

Jérémie Raso (J)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.

Amélia Julien (A)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.

Sébastien Hergalant (S)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France.

Aurélie François (A)

Lorraine Institute of Oncology, 54000, Nancy, France.

Lina Bezdetnaya (L)

Lorraine Institute of Oncology, 54000, Nancy, France.
CNRS, UMR_7039, CRAN (Centre de Recherche en Automatique de Nancy), Faculty of Medicine of Nancy, University of Lorraine, 54000, Vandoeuvre-lès-Nancy, France.

Guillaume Vogin (G)

UMR_7365, IMoPA (Ingénierie Moléculaire Et Ingénierie Articulaire), Faculty of Medicine of Nancy, CNRS-UL, University of Lorraine, 54000, Vandoeuvre-lès-Nancy, France.

Jean-Louis Guéant (JL)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France. jean-louis.gueant@univ-lorraine.fr.
Department of Molecular Medicine and Personalized Therapeutics, Department of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France. jean-louis.gueant@univ-lorraine.fr.
Reference Center for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France. jean-louis.gueant@univ-lorraine.fr.

Abderrahim Oussalah (A)

INSERM, UMR_S1256, NGERE (Nutrition, Genetics, and Environmental Risk Exposure), Faculty of Medicine of Nancy, University of Lorraine, 9 Avenue de la Forêt de Haye, 54000, Vandoeuvre-lès-Nancy, Nancy, France. abderrahim.oussalah@univ-lorraine.fr.
Department of Molecular Medicine and Personalized Therapeutics, Department of Biochemistry, Molecular Biology, Nutrition, and Metabolism, University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France. abderrahim.oussalah@univ-lorraine.fr.
Reference Center for Inborn Errors of Metabolism (ORPHA67872), University Hospital of Nancy, 54000, Vandoeuvre-lès-Nancy, France. abderrahim.oussalah@univ-lorraine.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH